Regulating Drug Prices while Increasing Innovation.

Conti, Rena M; Frank, Richard G; Gruber, Jonathan

Conti, Rena M; Frank, Richard G; Gruber, Jonathan.

Affiliation

Conti RM; From the Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston (R.M.C.); the USC-Brookings Schaeffer Initiative on Health Policy, Brookings Institution, Washington, DC (R.G.F.); and the Department of Economics, Massachusetts Institute of Technology, Cambridge (J.G.).
Frank RG; From the Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston (R.M.C.); the USC-Brookings Schaeffer Initiative on Health Policy, Brookings Institution, Washington, DC (R.G.F.); and the Department of Economics, Massachusetts Institute of Technology, Cambridge (J.G.).
Gruber J; From the Department of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston (R.M.C.); the USC-Brookings Schaeffer Initiative on Health Policy, Brookings Institution, Washington, DC (R.G.F.); and the Department of Economics, Massachusetts Institute of Technology, Cambridge (J.G.).

N Engl J Med ; 385(21): 1921-1923, 2021 Nov 18.

Article de En | MEDLINE | ID: mdl-34767322

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Medicare (USA) / Coûts des médicaments / Industrie pharmaceutique / Médicaments sur ordonnance / Développement de médicament Type d'étude: Health_economic_evaluation Pays/Région comme sujet: America do norte Langue: En Journal: N Engl J Med Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google